JP2023517035A5 - - Google Patents

Info

Publication number
JP2023517035A5
JP2023517035A5 JP2022553155A JP2022553155A JP2023517035A5 JP 2023517035 A5 JP2023517035 A5 JP 2023517035A5 JP 2022553155 A JP2022553155 A JP 2022553155A JP 2022553155 A JP2022553155 A JP 2022553155A JP 2023517035 A5 JP2023517035 A5 JP 2023517035A5
Authority
JP
Japan
Prior art keywords
composition
use according
subject
cells
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022553155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517035A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/055483 external-priority patent/WO2021176001A1/en
Publication of JP2023517035A publication Critical patent/JP2023517035A/ja
Publication of JP2023517035A5 publication Critical patent/JP2023517035A5/ja
Pending legal-status Critical Current

Links

JP2022553155A 2020-03-05 2021-03-04 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 Pending JP2023517035A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020900685A AU2020900685A0 (en) 2020-03-05 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
AU2020900685 2020-03-05
PCT/EP2021/055483 WO2021176001A1 (en) 2020-03-05 2021-03-04 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells

Publications (2)

Publication Number Publication Date
JP2023517035A JP2023517035A (ja) 2023-04-21
JP2023517035A5 true JP2023517035A5 (enExample) 2024-03-13

Family

ID=74867509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022553155A Pending JP2023517035A (ja) 2020-03-05 2021-03-04 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法

Country Status (9)

Country Link
US (1) US20230293589A1 (enExample)
EP (1) EP4114418B1 (enExample)
JP (1) JP2023517035A (enExample)
KR (1) KR20220150919A (enExample)
CN (1) CN115361958A (enExample)
AU (1) AU2021232614A1 (enExample)
BR (1) BR112022017557A2 (enExample)
CA (1) CA3170255A1 (enExample)
WO (1) WO2021176001A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4663241A3 (en) 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
IL299997A (en) * 2020-07-20 2023-03-01 Brainstorm Cell Therapeutics Ltd Methods and preparations for the treatment of lung conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
EP2298863B1 (en) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP4663241A3 (en) * 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
CN105796598A (zh) * 2014-12-29 2016-07-27 西比曼生物科技（上海）有限公司 一种用于治疗慢性阻塞性肺疾病的脂肪间充质祖细胞复合物
CN110139657A (zh) * 2017-02-15 2019-08-16 日本乐敦制药株式会社 肺纤维化治疗剂、ptprr表达促进剂及肺纤维化治疗用试剂盒
CL2017002357A1 (es) * 2017-09-16 2018-04-20 Cells For Cells S A Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos
CN111297899A (zh) * 2020-02-21 2020-06-19 云南雅盛医疗科技有限公司 一种脐带间充质干细胞在制备治疗新型冠状肺炎药物中的应用

Similar Documents

Publication Publication Date Title
Pickles et al. Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
Petersen et al. Aetiology of biliary atresia: what is actually known?
Ballard-Croft et al. Large-animal models of acute respiratory distress syndrome
Forrester et al. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings
Ackermann Lamb model of respiratory syncytial virus–associated lung disease: insights to pathogenesis and novel treatments
JP7464737B2 (ja) 肺上皮細胞の損傷及び／又は血管内皮細胞の損傷によって媒介される疾患の治療における低分子化合物の用途
JP2023520233A5 (enExample)
JP2023513847A5 (enExample)
Merolla et al. Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta.
WO2014126176A1 (ja) 炎症性疾患の予防又は治療用組成物
WO2021016727A1 (zh) 针对纤维化、炎症、和/或老化疾病的治疗药物
TW201709915A (zh) 用於治療肝臟疾病的間葉幹細胞
CN111407754A (zh) 卡谷氨酸在制备预防和治疗冠状病毒的药物中的应用
JP2023520233A (ja) 間葉系統前駆細胞又は幹細胞を使用する過炎症の治療方法
Tzouvelekis et al. Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect
JP7045670B2 (ja) 多能性幹細胞による虚血再灌流肺障害の軽減及び治療
JP2023519120A (ja) 温度応答型ウイルス貯蔵システム
CN115361958A (zh) 使用间充质谱系前体或干细胞治疗炎症性肺病的方法
WO2022056897A1 (zh) 白细胞介素37与干扰素联用在治疗病毒感染中的应用
Lis et al. Add-on treatment with nebulized hypertonic saline in a child with plastic bronchitis after the Glenn procedure
WO2021213488A1 (zh) 抑制细胞因子风暴的方法及组合物
Ehrsam et al. Lung transplantation in children
Distefano et al. Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn
JP2023535298A (ja) 急性呼吸器炎症状態およびサイトカインストーム症候群を処置する方法
Ngai et al. Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome